[go: up one dir, main page]

NO20000462L - 4-okso-3,5-dihydro-4H-pyridazino[4,5-b]indol-1-acetamid derivater, deres fremstilling og deres anvendelse i terapi - Google Patents

4-okso-3,5-dihydro-4H-pyridazino[4,5-b]indol-1-acetamid derivater, deres fremstilling og deres anvendelse i terapi

Info

Publication number
NO20000462L
NO20000462L NO20000462A NO20000462A NO20000462L NO 20000462 L NO20000462 L NO 20000462L NO 20000462 A NO20000462 A NO 20000462A NO 20000462 A NO20000462 A NO 20000462A NO 20000462 L NO20000462 L NO 20000462L
Authority
NO
Norway
Prior art keywords
pyridazino
indole
dihydro
oxo
therapy
Prior art date
Application number
NO20000462A
Other languages
English (en)
Other versions
NO20000462D0 (no
NO313963B1 (no
Inventor
Yannick Evanno
Laurent Dubois
Mireille Sevrin
Frank Marguet
Jacques Froissant
Regine Bartsch
Catherine Gille
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO20000462D0 publication Critical patent/NO20000462D0/no
Publication of NO20000462L publication Critical patent/NO20000462L/no
Publication of NO313963B1 publication Critical patent/NO313963B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20000462A 1997-07-30 2000-01-28 4-okso-3,5-dihydro-4H-pyridazino[4,5-b]indol-1-acetamid- derivater, medikamenter og farmasöytiske preparater NO313963B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9709692A FR2766823B1 (fr) 1997-07-30 1997-07-30 Derives de 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b] indole-1-acetamide, leur preparation et leur application en therapeutique
PCT/FR1998/001667 WO1999006406A1 (fr) 1997-07-30 1998-07-28 DERIVES DE 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b] INDOLE-1-ACETAMIDE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE

Publications (3)

Publication Number Publication Date
NO20000462D0 NO20000462D0 (no) 2000-01-28
NO20000462L true NO20000462L (no) 2000-03-29
NO313963B1 NO313963B1 (no) 2003-01-06

Family

ID=9509801

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000462A NO313963B1 (no) 1997-07-30 2000-01-28 4-okso-3,5-dihydro-4H-pyridazino[4,5-b]indol-1-acetamid- derivater, medikamenter og farmasöytiske preparater

Country Status (32)

Country Link
US (1) US6262045B1 (no)
EP (1) EP1000063B1 (no)
JP (1) JP4322421B2 (no)
KR (1) KR100497782B1 (no)
CN (1) CN1134440C (no)
AR (1) AR013264A1 (no)
AT (1) ATE226584T1 (no)
AU (1) AU736600B2 (no)
BG (1) BG64283B1 (no)
BR (1) BR9811582B1 (no)
CA (1) CA2298522C (no)
CO (1) CO5210883A1 (no)
CZ (1) CZ290011B6 (no)
DE (1) DE69808921T2 (no)
DK (1) DK1000063T3 (no)
EE (1) EE04317B1 (no)
ES (1) ES2186212T3 (no)
FR (1) FR2766823B1 (no)
HU (1) HU229430B1 (no)
IL (1) IL133633A (no)
NO (1) NO313963B1 (no)
NZ (1) NZ502361A (no)
PL (1) PL194245B1 (no)
PT (1) PT1000063E (no)
RU (1) RU2197490C2 (no)
SI (1) SI1000063T1 (no)
SK (1) SK283075B6 (no)
TR (1) TR200000278T2 (no)
TW (1) TW506971B (no)
UA (1) UA57088C2 (no)
WO (1) WO1999006406A1 (no)
ZA (1) ZA986786B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2788696B1 (fr) * 1999-01-26 2004-03-05 Synthelabo Utilisation de derives de pyridazino [4,5-b] indole-1-acetamide pour la preparation de medicaments destines aux maladies du systeme nerveux central
FR2788776B1 (fr) 1999-01-26 2001-02-23 Synthelabo Derives de 4-oxo-3, 5-dihydro-4h-pyridazino [4,5-b] indole-1 -carboxamide, leur preparation et leur application en therapeutique
GB0000564D0 (en) 2000-01-11 2000-03-01 Merck Sharp & Dohme Therapeutic agents
FR2811897A1 (fr) * 2000-07-24 2002-01-25 Sanofi Synthelabo UTILISATION DE DERIVES DE PYRIDAZINO[4,5-b]INDOLE-1- ACETAMIDE POUR LA PREPARATION DE MEDICAMENTS DESTINES AU TRAITEMENT DES DYSFONCTIONNEMENTS DES RECEPTEURS DE TYPE PERIPHERIQUE AUX BENZODIAZEPINES
FR2811990A1 (fr) * 2000-07-24 2002-01-25 Sanofi Synthelabo DERIVES DE 1-(4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOLE-1 -CARBONYL)PIPERAZINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2833953B1 (fr) * 2001-12-21 2004-12-03 Sanofi Synthelabo DERIVES DE 3-HETEROARYL-3,5-DIHYDRO-4-OXO-4H-PYRIDAZINO [4,5-b]INDOLE-1-CARBOXAMIDE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2838124B1 (fr) * 2002-04-03 2004-05-28 Sanofi Synthelabo Derives de 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino [4,5-b]indole-1-acetamide, leur preparation et leur application en therapeutique
WO2006061392A2 (en) * 2004-12-07 2006-06-15 Janssen Pharmaceutica N.V. Substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives
BRPI0611433A2 (pt) * 2005-05-05 2010-09-08 Sanofi Aventis Us Llc formulações estáveis de nanopartìcula
WO2007027525A1 (en) * 2005-08-29 2007-03-08 Sanofi-Aventis U.S. Llc Novel crystalline form of a pyridazino [4 , 5-b] indole derivative
ZA200801893B (en) * 2005-08-29 2009-08-26 Sanofi Aventis Us Llc Amorphous solid dispersions of 7-chloro-N,N, 5-Trimethyl-4-Oxo-3-phenyl-3, 5,-dihydro-4H-pyridazino [4,5-B] indole-1-acetamide
JP2009508966A (ja) * 2005-09-23 2009-03-05 シェーリング コーポレイション 治療薬としての縮合四環性ｍＧｌｕＲ１アンタゴニスト
CN1946120B (zh) * 2006-10-20 2010-05-12 华为技术有限公司 实现话单关联的方法及系统
AU2009283039A1 (en) * 2008-08-18 2010-02-25 Sanofi-Aventis U.S. Llc Process for preparing polymorph of 7-chloro-N, N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydr0-4H-pyridazin0[4,5-b]indole-1-acetamide
EP2181717A1 (en) 2008-10-28 2010-05-05 Sanofi-Aventis Use of 7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-B]indole-1-acetamide as a biomarker of peripheral benzodiazepine receptor levels

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4985560A (en) * 1990-01-12 1991-01-15 American Home Products Corporation Pyridazino(4,5-b)indolizines
FI94531C (fi) * 1990-03-13 1995-09-25 Ime Intermed Enterpris Sa Menetelmä farmaseuttisesti aktiivisen 1,3,4,6,7,8-heksahydro-2H-pyrimido-(1,2-a)-pyrimidiinijohdannaisen valmistamiseksi
GB9411955D0 (en) * 1994-06-15 1994-08-03 Merck Sharp & Dohme Therapeutic agents
US5756501A (en) * 1995-12-13 1998-05-26 American Home Products Corporation Saturated and unsaturated pyridazino 4,5-B! indolizines useful as antidementia agents
FR2754262B1 (fr) 1996-10-08 1998-10-30 Synthelabo Derives de 1h-pyrido[3,4-b]indole-4-carboxamide, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
CN1134440C (zh) 2004-01-14
AR013264A1 (es) 2000-12-13
ATE226584T1 (de) 2002-11-15
BG64283B1 (bg) 2004-08-31
EP1000063A1 (fr) 2000-05-17
IL133633A0 (en) 2001-04-30
CZ2000320A3 (cs) 2000-05-17
BR9811582B1 (pt) 2010-10-19
NO20000462D0 (no) 2000-01-28
SK1292000A3 (en) 2000-08-14
TW506971B (en) 2002-10-21
CO5210883A1 (es) 2002-10-30
FR2766823B1 (fr) 1999-10-08
US6262045B1 (en) 2001-07-17
PT1000063E (pt) 2003-03-31
RU2197490C2 (ru) 2003-01-27
HU229430B1 (en) 2013-12-30
CA2298522A1 (en) 1999-02-11
DK1000063T3 (da) 2003-02-24
EE200000056A (et) 2000-10-16
DE69808921T2 (de) 2003-07-03
PL338445A1 (en) 2000-11-06
AU736600B2 (en) 2001-08-02
HUP0002650A3 (en) 2002-09-30
ES2186212T3 (es) 2003-05-01
BR9811582A (pt) 2000-09-26
WO1999006406A1 (fr) 1999-02-11
NO313963B1 (no) 2003-01-06
SK283075B6 (sk) 2003-02-04
ZA986786B (en) 1999-02-02
TR200000278T2 (tr) 2000-08-21
NZ502361A (en) 2001-06-29
EE04317B1 (et) 2004-06-15
KR20010022356A (ko) 2001-03-15
CA2298522C (en) 2008-07-15
AU8983298A (en) 1999-02-22
JP4322421B2 (ja) 2009-09-02
CZ290011B6 (cs) 2002-05-15
HK1028027A1 (en) 2001-02-02
BG104096A (en) 2000-08-31
PL194245B1 (pl) 2007-05-31
EP1000063B1 (fr) 2002-10-23
UA57088C2 (uk) 2003-06-16
JP2001512122A (ja) 2001-08-21
DE69808921D1 (de) 2002-11-28
HUP0002650A2 (hu) 2001-01-29
SI1000063T1 (en) 2003-04-30
KR100497782B1 (ko) 2005-06-27
CN1265108A (zh) 2000-08-30
IL133633A (en) 2004-02-08
FR2766823A1 (fr) 1999-02-05

Similar Documents

Publication Publication Date Title
DK0869126T3 (da) Dithiolanderivater, deres fremstilling og deres terapeutiske virkning
DK1418176T3 (da) Pyrazolderivater, deres fremstilling og deres anvendelse i lægemidler
EE200200414A (et) Dihüdro-1,3,5-triasiinamino derivaadid ja nende kasutamine ravis
NO985977D0 (no) Spiro-piperidinderivater og deres anvendelse som terapeutiske midler
FI944600A0 (fi) Imidatsol-4-yylipiperidiinijohdannaisia, niiden valmistus ja niiden käyttö terapiassa
PL352330A1 (en) Derivatives of pyridopyranoazepine, making of same and use of same in therapy
NO20000462L (no) 4-okso-3,5-dihydro-4H-pyridazino[4,5-b]indol-1-acetamid derivater, deres fremstilling og deres anvendelse i terapi
NO991624D0 (no) 1H-pyrido[3,4-b]indol-4-karboksamid-derivater, fremstilling og anvendelse derav i terapeutiske midler
NO975020D0 (no) Azacykloalkanderivater, fremstilling derav og deres anvendelse i terapi
DK0927184T3 (da) 3-substituerede pyrido[4',3':4,5]thieno-[2,3-d]pyrimidinderivater, deres fremstilling og anvendelse
NO992676D0 (no) 1,4-diazabicyklo[2,2,2]okt-2-ylmetylderivater, deres fremstilling og terapeutiske anvendelse
NO953673D0 (no) [1,2,4ÅTriazolo[4,3-aÅkinoksalinderivater, deres fremstilling og anvendelse
NO20001934D0 (no) 3-Substituerte tetrahydropyridopyrimidinon-derivater, deres fremstilling og anvendelse
EE9800333A (et) Uued furaandiarüülmetülideeni derivaadid, nende valmistamise meetod ja kasutamine teraapias
EE9900414A (et) 2,3-dihüdrofuro[3,2-b]püridiini derivaadid, nende valmistamine ja kasutamine raviks
EE200000207A (et) 8-asabitsüklo[3.2.1]oktaan-3-metaanamiini derivaadid, nende valmistamine ja terapeutiline kasutamine
DE60002043D1 (de) 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b]indol-1-carboxamid-derivate, ihre herstellung und therapeutische verwendung
NO991581D0 (no) N-(benzotiazol-2-yl)piperidin-1-etanaminderivater, deres fremstilling og anvendelse i terapeutiske midler
IL123156A0 (en) Benzenesulphonamide derivatives their preparation and their application in therapy
IL133536A0 (en) 6-pyrrolidin-2-ylpyridine derivatives, their preparation and application in therapy
FI954141L (fi) Oksatsolokinolonijohdannaiset, niiden valmistus ja niiden käyttö terapiassa
ZA982369B (en) Dihydropyrazino[1,2-a]indol-1-one derivatives their preparation and their use in therapy
DK1458721T3 (da) 3-heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-b]indol-1-carbox-amidderivater, deres fremstilling og terapeutisk anvendelse
NO950560D0 (no) Piperazinderivater, deres fremstilling og terapautiske anvendelse
AU6924198A (en) Benzenesulphonamide derivatives, preparation and application thereof in therapy

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees